Lucy An is currently pursuing a Master of Business Administration at The Wharton School, following a Bachelor of Arts in Molecular and Cell Biology and Economics from the University of California, Berkeley. They have garnered experience as an MBA Intern in the Commercial Leadership Program at MannKind Corporation, focusing on the commercialization of inhaled insulin and clofazamine. Previously, Lucy worked as a Senior Consultant for Deloitte Consulting, specializing in Healthcare & Life Sciences, and as a Summer Consultant for Oliver Wyman, where they helped devise a ten-year strategy for a Bay Area health system. Their research experience includes roles at the University of California, Berkeley's Hsu Lab and The Scripps Research Institute.
This person is not in the org chart
This person is not in any teams
This person is not in any offices